Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...
Researchers at the University of Toronto say they have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine ...
In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...
This interview addresses the challenges and complexities of developing and manufacturing controlled-release drug formulations. Could you introduce yourself and your expertise in drug development and ...
Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...
LONDON--(BUSINESS WIRE)--The Pharmaceutical Formulation Equipment market will register an incremental spend of about USD 7.35 billion, growing at a CAGR of 8.42% during the five-year forecast period.
insights from industryShanoo BudhdeoDirector of Pharmaceutical ScienceSeda Pharmaceutical Development Services In this interview, NewsMedical speaks with Shanoo about her career progression and role ...
Sponsored by Specac LtdReviewed by Maria OsipovaOct 15 2025 Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results